132 related articles for article (PubMed ID: 37865062)
1. Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation.
Dębczyński M; Mojsak D; Tamburro S; Baldassari S; Musante I; Casciaro R; Ciciriello F; Zara F; Scudieri P; Gorrieri G
Stem Cell Res; 2023 Oct; 72():103232. PubMed ID: 37865062
[TBL] [Abstract][Full Text] [Related]
2. Generation of human induced pluripotent stem cells from cystic fibrosis patient carrying nonsense mutation (p.S308X) in CFTR gene.
Khor W; Hwang TC; Wang CC; Yarmishyn AA; Yeh JT; Chiou SH; Chou SJ
Stem Cell Res; 2022 Apr; 60():102683. PubMed ID: 35091309
[TBL] [Abstract][Full Text] [Related]
3. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene.
Kondrateva E; Panchuk I; Demchenko A; Grigorieva O; Zheglo D; Voronina E; Erofeeva A; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2022 Aug; 63():102854. PubMed ID: 35843019
[TBL] [Abstract][Full Text] [Related]
5. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
Sermet-Gaudelus I; Renouil M; Fajac A; Bidou L; Parbaille B; Pierrot S; Davy N; Bismuth E; Reinert P; Lenoir G; Lesure JF; Rousset JP; Edelman A
BMC Med; 2007 Mar; 5():5. PubMed ID: 17394637
[TBL] [Abstract][Full Text] [Related]
6. Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation.
Merkert S; Schubert M; Haase A; Janssens HM; Scholte B; Lachmann N; Göhring G; Martin U
Stem Cell Res; 2020 Apr; 44():101744. PubMed ID: 32220772
[TBL] [Abstract][Full Text] [Related]
7. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
[TBL] [Abstract][Full Text] [Related]
8. Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids.
Crawford DK; Mullenders J; Pott J; Boj SF; Landskroner-Eiger S; Goddeeris MM
J Cyst Fibros; 2021 May; 20(3):436-442. PubMed ID: 33558100
[TBL] [Abstract][Full Text] [Related]
9. Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor.
Xue X; Mutyam V; Tang L; Biswas S; Du M; Jackson LA; Dai Y; Belakhov V; Shalev M; Chen F; Schacht J; J Bridges R; Baasov T; Hong J; Bedwell DM; Rowe SM
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):805-16. PubMed ID: 24251786
[TBL] [Abstract][Full Text] [Related]
10. A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies.
McHugh DR; Steele MS; Valerio DM; Miron A; Mann RJ; LePage DF; Conlon RA; Cotton CU; Drumm ML; Hodges CA
PLoS One; 2018; 13(6):e0199573. PubMed ID: 29924856
[TBL] [Abstract][Full Text] [Related]
11. Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model.
Du M; Keeling KM; Fan L; Liu X; Kovaçs T; Sorscher E; Bedwell DM
J Mol Med (Berl); 2006 Jul; 84(7):573-82. PubMed ID: 16541275
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene.
Du M; Jones JR; Lanier J; Keeling KM; Lindsey JR; Tousson A; Bebök Z; Whitsett JA; Dey CR; Colledge WH; Evans MJ; Sorscher EJ; Bedwell DM
J Mol Med (Berl); 2002 Sep; 80(9):595-604. PubMed ID: 12226741
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
[TBL] [Abstract][Full Text] [Related]
14. Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells.
Li C; Liu Z; Anderson J; Liu Z; Tang L; Li Y; Peng N; Chen J; Liu X; Fu L; Townes TM; Rowe SM; Bedwell DM; Guimbellot J; Zhao R
PLoS One; 2023; 18(11):e0295009. PubMed ID: 38019847
[TBL] [Abstract][Full Text] [Related]
15. Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR.
Smith E; Dukovski D; Shumate J; Scampavia L; Miller JP; Spicer TP
SLAS Discov; 2021 Feb; 26(2):205-215. PubMed ID: 33016182
[TBL] [Abstract][Full Text] [Related]
16. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model.
Du M; Liu X; Welch EM; Hirawat S; Peltz SW; Bedwell DM
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2064-9. PubMed ID: 18272502
[TBL] [Abstract][Full Text] [Related]
17. Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients.
Fleischer A; Lorenzo IM; Palomino E; Aasen T; Gómez F; Servera M; Asensio VJ; Gálvez V; Izpisúa-Belmonte JC; Bachiller D
Stem Cell Res; 2018 May; 29():1-5. PubMed ID: 29554588
[TBL] [Abstract][Full Text] [Related]
18. Generation of two induced pluripotent stem cell lines (RCMGi004-A and -B) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/W1282X mutations in CFTR gene.
Kondrateva E; Demchenko A; Slesarenko Y; Pozhitnova V; Yasinovsky M; Amelina E; Tabakov V; Voronina E; Lavrov A; Smirnikhina S
Stem Cell Res; 2021 Apr; 52():102232. PubMed ID: 33607467
[TBL] [Abstract][Full Text] [Related]
19. Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cells.
Valley HC; Bukis KM; Bell A; Cheng Y; Wong E; Jordan NJ; Allaire NE; Sivachenko A; Liang F; Bihler H; Thomas PJ; Mahiou J; Mense M
J Cyst Fibros; 2019 Jul; 18(4):476-483. PubMed ID: 30563749
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene.
Venturini A; Borrelli A; Musante I; Scudieri P; Capurro V; Renda M; Pedemonte N; Galietta LJV
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
